Ignite Creation Date:
2024-05-06 @ 3:40 AM
Last Modification Date:
2024-10-26 @ 11:37 AM
Study NCT ID:
NCT02342379
Status:
COMPLETED
Last Update Posted:
2020-04-10
First Post:
2015-01-14
Brief Title:
TH-302 in Combination With Bevacizumab for Glioblastoma
Sponsor:
The University of Texas Health Science Center at San Antonio
Organization:
The University of Texas Health Science Center at San Antonio
Organization Data
Organization:
The University of Texas Health Science Center at San Antonio
Class:
OTHER
Study ID:
CTRC 12-0105
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
The University of Texas Health Science Center at San Antonio
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None